Two Sigma Investments
BNTX icon

Two Sigma Investments’s BioNTech BNTX Stock Holding History

Two Sigma Investments’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-45,400
Closed -$11.7M – 2821
2021
Q4 		$11.7M Buy
45,400
+8,700
+24% +$2.38M 0.03% 705
2021
Q3 		$10M Buy
36,700
+22,700
+162% +$7.21M 0.02% 776
2021
Q2 		$3.13M Buy
+14,000
New +$2.64M 0.01% 1517

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's BNTX Position: Q1 2026 in Review

Two Sigma Investments increased its BioNTech (BNTX) stake by 54% in Q1 2026, buying an estimated $5.95M and bringing the position to 166,179 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #1148.

Two Sigma Investments first reported a position in BNTX in Q4 2020 and has held it in 10 quarters since. The position peaked at $62.3M in Q2 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Two Sigma Investments held 166,179 shares of BioNTech worth $14.8M as of Q1 2026.
  • Two Sigma Investments bought 57,921 BioNTech shares in Q1 2026, an estimated $5.95M.
  • BioNTech made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1148 holding.
  • Two Sigma Investments first reported a position in BioNTech in Q4 2020 and has held it in 10 quarters since.
  • Two Sigma Investments's BioNTech position peaked at $62.3M in Q2 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.